Substrate utilization in sepsis and multiple organ failure

Critical Care Medicine

Volumn 35, Issue 9 SUPPL., 2007, Pages

  Tappy, Luc ^a   Chioléro, René ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Energy expenditure; Fish oil; Glucose production; Lactate; Lipolysis; Proteolysis

Indexed keywords

ADENOSINE TRIPHOSPHATE; BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; FISH OIL; GLUCOSE; LACTIC ACID; LIPID; OMEGA 3 FATTY ACID; PROTEIN; STRESS HORMONE; TUMOR NECROSIS FACTOR ALPHA;

CELL FUNCTION; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; CRITICAL ILLNESS; ENERGY EXPENDITURE; ENERGY METABOLISM; ENZYME ACTIVATION; GLUCOSE METABOLISM; HUMAN; HYPERLACTATEMIA; IMMUNOCOMPETENT CELL; LIPID OXIDATION; LIPOLYSIS; METABOLIC ACTIVATION; MULTIPLE ORGAN FAILURE; MUSCLE MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; SEPSIS;

CRITICAL ILLNESS; ENERGY METABOLISM; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; INFLAMMATION MEDIATORS; LACTIC ACID; LIPOPOLYSACCHARIDES; MULTIPLE ORGAN FAILURE; SEPSIS;

EID: 34548191572     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000278062.28122.A4     Document Type: Conference Paper

References (45)

1. Michie HR: Metabolism of sepsis and multiple organ failure. World J Surg 1996; 20:460-464
2. Campbell IT: Limitations of nutrient intake: The effects of stressors. Trauma, sepsis and multiple organ failure. Eur J Clin Nutr 1999; 53:S143-S147
3. Ingels C, Debaveye Y, Milants I, et al: Strict blood glucose control with insulin during intensive care after cardiac surgery: Impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J 2006; 27:2716-2724
4. Van den Berghe G, Wilmer A, Milants I, et al: Intensive insulin therapy in mixed medical/surgical intensive care units: Benefit versus harm. Diabetes 2006; 55:3151-3159
5. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554
6. Russell JA: Drug therapy: Management of sepsis. N Engl J Med 2006; 355:1699-1713
7. Djillani A, Bellisant E, Cavaillon JM: Septic shock. Lancet 2005; 365:63-78
8. Kreymann G, Grosser S, Buggisch P, et al: Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome, and septic shock. Crit Care Med 1993; 21:1012-1019
9. Martinez A, Chiolero R, Bollman M, et al: Assessment of adipose tissue metabolism by means of subcutaneous microdialysis in patients with sepsis or circulatory failure. Clin Physiol Funct Imaging 2003; 23:286-292
10. Hasselgren PO, Fischer JE: Counter-regulatory hormones and mechanisms in amino acid metabolism with special reference to the catabolic response in skeletal muscle. Curr Opin Clin Nutr Metab Care 1999; 2:9-14
11. Leverve X: Inter-organ substrate exchanges in the critically ill. Curr Opin Clin Nutr Metab Care 2001; 4:137-142
12. Gelfand RA, Matthews DE, Bier D, et al: Role of counterregulatory hormones in the catabolic response to stress. J Clin Invest 1984; 74:2238-2248
13. Petit F, Bagby GJ, Lang CH: Tumor necrosis factor mediates zymosan-induced increase in glucose flux and insulin resistance. Am J Physiol 1995; 268:E219-E228
14. Plomgaard P, Bouzakri K, Krogh-Madsen R, et al: Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 2005; 54:2939-2945
15. Wolfe RR, Herndon DN, Jahoor F, et al: Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 1987; 317:403-408
16. Druml W, Fischer M, Ratheiser K: Use of intravenous lipids in critically ill patients with sepsis without and with hepatic failure. JPEN J Parenter Enteral Nutr 1998; 22:217-223
17. Lind L, Lithell H: Impaired glucose and lipid metabolism seen in intensive care patients is related to severity of illness and survival. Clin Intensive Care 1994; 5:100-105
18. Rashkin MC, Bosken C, Baughman RP: Oxygen delivery in critically ill patients: Relationship to blood lactate and survival. Chest 1985; 87:580-584
19. Chiolero RL, Revelly JP, Leverve X, et al: Effects of cardiogenic shock on lactate and glucose metabolism after heart surgery. Crit Care Med 2000; 28:3784-3791
20. Levraut J, Ciebera JP, Chave S, et al: Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med 1998; 157:1021-1026
21. +-ATPase and raises blood lactate under aerobic conditions in humans. Am J Physiol Heart Circ Physiol 2003; 284:H1028-H1034
22. James JH, Fang CH, Schrantz SJ, et al: Linkage of aerobic glycolysis to sodium-potassium transport in rat skeletal muscle: Implications for increased muscle lactate production in sepsis. J Clin Invest 1996; 98:2388-2397
23. Lopez-Villegas D, Lenkinski RE, Wehrli SL, et al: Lactate production by human monocytes/ macrophages determined by proton MR spectroscopy. Magn Reson Med 1995; 34:32-38
24. Revelly JP, Tappy L, Martinez A, et al: Lactate and glucose metabolism in severe sepsis and cardiogenic shock. Crit Care Med 2005; 33:2235-2240
25. Fredriksson K, Hammarqvist F, Strigard K, et al: Derangement in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure. Am J Physiol Endocrinol Metab 2006; 291:E1044-E1050
26. Stacpoole PW, Wright EC, Baumgartner TG, et al: A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults: The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med 1992; 327:1564-1569
27. Bollmann M, Revelly JP, Tappy L, et al: Effect of bicarbonate and lactate buffer on glucose and lactate metabolism during hemodiafiltration in patients with multiple organ failure. Intensive Care Med 2004; 30:1103-1110
28. 2 assessed by a cyclooxygenase inhibitor. J Clin Endocrinol Metab 1993; 77:1156-1163
29. Michaeli B, Berger MM, Revelly JP, et al: Effects of fish oil on the neuro-endocrine responses to an endotoxin challenge in healthy volunteers. Clin Nutr 2007; 26:70-77
30. Borovikova LV, Ivanova S, Zhang M, et al: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405:458-462
31. Van der Poll T, Romijn JA, Endert E, et al: Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 1991; 261:E457-E465
32. Sugita H, Kaneki M, Tokunaga E, et al: Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab 2002; 282:E386-E394
33. Agwunobi AO, Reid C, Maycock P, et al: Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab 2000; 85:3770-3778
34. Bastian L, Weimann A: Immunonutrition in patients after multiple trauma. Br J Nutr 2002; 87:S133-S134
35. Calder PC: n-3 Fatty acids, inflammation, and immunity: Relevance to postsurgical and critically ill patients. Lipids 2004; 39:1147-1161
36. Peet M, Stokes C: Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs 2005; 65:1051-1059
37. Delarue J, Matzinger O, Binnert C, et al: Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes Metab 2003; 29:289-295
38. Harris WS: n-3 Fatty acids and serum lipoproteins: Human studies. Am J Clin Nutr 1997; 65:1645S-1654S
39. Harris WS: n-3 Fatty acids and serum lipoproteins: Animal studies. Am J Clin Nutr 1997; 65:1611S-1616S
40. Woodman RJ, Mori TA, Burke V, et al: Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 2002; 76:1007-1015
41. Holness MJ, Greenwood GK, Smith ND, et al: Diabetogenic impact of long-chain omega-3 fatty acids on pancreatic beta-cell function and the regulation of endogenous glucose production. Endocrinology 2003; 144:3958-3968
42. Puhakainen I, Ahola I, Yki-Jarvinen H: Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1995; 61:121-126
43. Zambon S, Friday KE, Childs MT, et al: Effect of glyburide and omega 3 fatty acid dietary supplements on glucose and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1992; 56:447-454
44. Tappy L, Berger MM, Schwarz JM, et al: Metabolic effects of parenteral nutrition enriched with n-3 polyunsaturated fatty acids in critically ill patients Clin Nutr 2006; 25:588-595
45. Seematter G, Binnert C, Martin JL, et al: Relationship between stress, inflammation and metabolism. Curr Opin Clin Nutr Metab Care 2004; 7:169-173